栄養素の競争:腫瘍免疫抑制の新たな軸
Madhusudhanan Sukumar1, Rahul Roychoudhuri1, Nicholas P Restifo1
1Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health Bethesda, MD 20892, USA.
Cell
|September 12, 2015
まとめ
ガン細胞は成長のためにウォーバーグの代謝を利用し,T細胞のグルコースを制限することで抗腫瘍免疫を抑制します. この代謝適応は免疫系を阻害する
科学分野:
- 腫瘍学
- 免疫学
- 代謝経路
背景:
- 癌細胞は 急速な成長と増殖を促すため ウォーバーグ効果として知られる 代謝の変化を示します
- ワルバーグ効果は,がん細胞の高い生物合成要求を満たす仮説である.
研究 の 目的:
- 腫瘍の微小環境内の免疫抑制における ウォーバーグの代謝の役割を調査する.
- ガン細胞の代謝がT細胞の機能と抗腫瘍免疫にどのように影響するかを理解する.
主な方法:
- 癌細胞の代謝経路の分析
- 腫瘍細胞の存在におけるT細胞に対するグルコースの可用性の評価
- 腫瘍の微小環境におけるT細胞活動と増殖の評価
主要な成果:
- 癌細胞におけるワーブルグ代謝は,グルコースの利用を制限する.
- T細胞へのグルコース供給の制限は,その抗腫瘍機能を損なう.
- 腫瘍細胞のウォーバーグ代謝は,抗腫瘍免疫反応を活発に抑制する.
結論:
- ガン細胞が免疫監視を回避する 重要なメカニズムです
- ガン細胞の代謝をターゲットにすることで 抗腫瘍免疫力を高める 戦略となるかもしれません
さらに関連する動画
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
8.3K
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
6.6K
関連する概念動画
Tumor Immunotherapy
2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
The Tumor Microenvironment
8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
The Tumor Microenvironment
3.1K
3.1K
Tumor Progression
7.9K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.9K
Tumor Progression
3.6K
3.6K
Cancer Stem Cells and Tumor Maintenance
6.4K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K
